FRM 2018 Conference Chairs
David F. Albertini
MD, PhD, USA
- Recognize state-of-the-arts developments in reproductive biology and their translational potential for clinical practice in reproductive endocrinology and infertility.
- Identify paradigm changes in clinical reproductive medicine, driven by new discoveries in reproductive biology.
- Evaluate current popular infertility treatments in selected patient populations.
- Apply individualized infertility medicine based on age and functional ovarian reserve of female patients.
Who Should Attend?
With knowledge attained through molecular embryology having become central in so many areas of medicine, from stem cell science to immunology, reproductive medicine, oncology and regenerative medicine to mention only a few, attendance in this conference will be of interest to many, if not most, medical specialty areas.
It will be of particular interest to obstetrician-gynecologists, clinical fertility specialists and reproductive as well as medical endocrinologists. Among basic scientists, reproductive biologists, embryologists, stem cell scientists, and reproductive geneticists will benefit from attending.
The FRM is especially interested in facilitating attendance by postdocs, residents, fellows and other professional junior staff members of research laboratories, academic departments and IVF programs and, therefore, offers greatly discounted registration fees to such junior staff members with presentation of a letter from their program director.